Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 1, keine Gesamtzahl für „Peyona“
Suchtreffer
Begriffe & Kennungen
Peyona (previously Nymusa)
Eintrag öffnenPeyona (previously Nymusa) · 4.1 Therapeutic indications · 1
Eintrag öffnenPeyona (previously Nymusa) · 4.3 Contraindications · 1
Eintrag öffnenPeyona (previously Nymusa) · 4.3 · Hypersensitivity to the active substance or to any of the excipients listed in section 6.1.
Eintrag öffnenPeyona (previously Nymusa) · 4.4 Special warnings and precautions for use · 1
Eintrag öffnenPeyona (previously Nymusa) · 4.5 Interaction with other medicinal products and other forms of interaction · 1
Eintrag öffnenPeyona (previously Nymusa) · 4.5 · 5 Although few data exist on interactions of caffeine with other active substances in preterm newborn infants,
Eintrag öffnenPeyona (previously Nymusa) · 4.5 · Cytochrome P450 1A2 (CYP1A2) is the major enzyme involved in the metabolism of caffeine in humans. Therefore,
Eintrag öffnenPeyona (previously Nymusa) · 4.5 · Inter-conversion between caffeine and theophylline occurs in preterm newborn infants. These active substances
Eintrag öffnenPeyona (previously Nymusa) · 4.6 Fertility, pregnancy and lactation · 1
Eintrag öffnenPeyona (previously Nymusa) · 4.8 Undesirable effects · 1
Eintrag öffnenPeyona (previously Nymusa) · 4.8 · 6 Frequency is defined as: very common (1/10), common (1/100 to 1/10), uncommon (1/1,000 to 1/100), rare
Eintrag öffnenPeyona (previously Nymusa) · 4.8 · Cardiac disorders Tachycardia Common Arrhythmia Uncommon Increased left ventricular output and Not known incre
Eintrag öffnenPeyona (previously Nymusa) · 4.8 · Description of selected adverse reactions
Eintrag öffnenPeyona (previously Nymusa) · 4.8 · In a post-authorisation safety study on 506 preterm infants treated with Peyona, safety data have been collect
Eintrag öffnenPeyona (previously Nymusa) · 4.8 · Necrotising enterocolitis is a common cause of morbidity and mortality in premature newborn infants. There are
Eintrag öffnenPeyona (previously Nymusa) · 4.8 · Other special populations
Eintrag öffnenPeyona (previously Nymusa) · 4.8 · Reporting of suspected adverse reactions
Eintrag öffnenPeyona (previously Nymusa) · 4.8 · Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows con
Eintrag öffnenPeyona (previously Nymusa) · 4.8 · Summary of the safety profile
Eintrag öffnen